L

Lablite

Optimising clinical care strategies and laboratory monitoring for cost-effective roll-out of antiretroviral therapy in Africa: the Lablite project

LATA

Long-Acting Treatment in Adolescents (LATA): A randomised, open-label, two-arm, 96 week trial in virologically suppressed HIV-1-positive adolescents aged 12-19 years of age in sub-Saharan Africa

Leg Ulcers: Bandage comparison, systematic review and IPD meta-analysis

Four-layer compression bandage compared with short stretch bandage for venous leg ulcers: A systematic review and meta-analysis of randomised controlled trials of individual patient data

LU09

Three versus six courses of etoposide, cyclophosphamide, methotrexate and voncristine versus six courses of etoposide and ifosfamide in small cell lung cancer

LU10

A phase II trial of alternating chemotherapy and radiotherapy in small cell lung cancer

LU11

A randomised trial of post-operative radiotherapy in non-small cell lung cancer

LU12

A randomised trial of 4-drug vs less intensive 2-drug chemotherapy in the palliative treatment of patients with non-small cell lung cancer and a poor prognosis

LU13

A randomised trial of palliative 2-fraction vs more intensive 13-fraction radiotherapy for patients with inoperable NSCLC and a good performance status

LU14

Adding GCSF (lenograstim) to chemotherapy to try and increase the dose intensity of chemotherapy given to patients with small cell lung cancer

LU15

Adding GCSF (filgrastim) to chemotherapy to try and increase the dose intensity of chemotherapy given to patients with small cell lung cancer

LU16

A randomised trial of oral etoposide vs intravenous multi-drug chemotherapy in the palliative treatment of patients with small cell lung cancer and a poor prognosis

LU17

A randomised trial of supportive treatment with or without immediate thoracic radiotherapy in the prevention and palliation of symptoms in patients with inoperable non-small cell lung cancer and minimal thoracic symptoms

LU18

A randomised controlled clinical trial of endobronchial treatment versus external beam radiotherapy in the management of endotracheal or endobronchial obstruction by lung cancer

LU19

A randomised controlled intensification clinical trial of chemotherapy with or without recombinant human granulocyte colony stimulating factor (G-CSF) in small-cell lung cancer

LU20

A randomised trial of neo-adjuvant chemotherapy followed by resection versus radiotherapy in patients with T3, N1, M0 or T1-3, N2, M0 non-small cell lung cancer (NSCLC)

LU21

A randomised clinical trial of isosfamide, carboplatin and etoposide with mid-cycle vincristine (ICE-V) versus standard practice chemotherapy in patient with small-cell lung cancer (SCLC) and good performance status

LU22

Surgical resection with or without pre-operative chemotherapy in patients with operable non-small cell lung cancer

Lung cancer: preoperative chemotherapy, systematic review and IPD meta-analysis

Preoperative chemotherapy for non-small cell lung cancer: a systematic review and meta-analysis of individual participant data

Lung cancer: chemotherapy, surgery, radiotherapy, two systematic reviews and IPD meta-analyses

Adjuvant chemotherapy and surgery (with or without radiotherapy) versus surgery (with or without radiotherapy) for non-small cell lung cancer: Two systematic reviews and meta-analyses of individual patient data

Lung cancer: chemotherapy and supportive care, a systematic review and IPD meta-analysis

Chemotherapy and supportive care versus supportive care for advanced non-small cell lung cancer: A systematic review and meta-analysis of individual patient data

Lung cancer: TKI inhibitors, systematic review and aggregate data meta-analysis

Should tyrosine kinase inhibitors be considered for advanced non-small cell lung cancer with wild type EGFR? Two systematic reviews and meta-analyses of randomised trials

Lung cancer: post-operative radiotherapy, a systematic review and IPD meta-analysis

Postoperative radiotherapy for nonā€small cell lung cancer

LY06

A multicentre evaluation of National Cancer Institute protocol 89-C-41 (with minor modifications) in Burkitt or Burkitt-like non-Hodgkin lymphoma

LY09

A randomised trial of therapy for advanced Hodgkin lymphoma